In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: Formula AA or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

##STR00001##

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: Formula AA or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

##STR00001##

A hydrophobic palladium/metal organic framework (MOF) material, which is a solid catalyst material obtained by taking a porous MOF as a carrier, introducing elementary palladium by means of an immersion-reduction method, and performing polydimethylsiloxane coating layer processing. A method which uses hydrophobic palladium/MOF material to selectively catalyze hexoses to prepare 2,5-dimethylfuran comprises: dissolving a hexose into an alcohol; using the hydrophobic palladium/MOF material as a catalyst and polymethylhydrosiloxane as a hydrogen donor, reacting at 70 to 130° C. for 0.25 to 12 h under the action of an acidic additive; the concentration of the hexose in the alcohol is 0.2 to 10 wt %, and the total amount of Pd contained in the hydrophobic palladium/MOF material relative to a hexose is 0.1 to 5 mol %. The hydrophobic palladium/MOF material has a stable structure, and under the same conditions, has a catalyzing efficiency which is significantly higher than that of commercially available palladium on carbon and common palladium/MOF materials.

A hydrophobic palladium/metal organic framework (MOF) material, which is a solid catalyst material obtained by taking a porous MOF as a carrier, introducing elementary palladium by means of an immersion-reduction method, and performing polydimethylsiloxane coating layer processing. A method which uses hydrophobic palladium/MOF material to selectively catalyze hexoses to prepare 2,5-dimethylfuran comprises: dissolving a hexose into an alcohol; using the hydrophobic palladium/MOF material as a catalyst and polymethylhydrosiloxane as a hydrogen donor, reacting at 70 to 130° C. for 0.25 to 12 h under the action of an acidic additive; the concentration of the hexose in the alcohol is 0.2 to 10 wt %, and the total amount of Pd contained in the hydrophobic palladium/MOF material relative to a hexose is 0.1 to 5 mol %. The hydrophobic palladium/MOF material has a stable structure, and under the same conditions, has a catalyzing efficiency which is significantly higher than that of commercially available palladium on carbon and common palladium/MOF materials.

The invention relates to methods of hydrodeoxygenation of oxygenated compounds into compounds with unsaturated carbon-carbon bonds, comprising the steps of: a) providing a reaction mixture comprising, an oxygenated compound containing one or more of a hydroxyl, keto or aldehyde group, an ionic liquid, a homogeneous metal catalyst, and carbon monoxide or a carbon monoxide releasing compound, b) reacting said reaction mixture under a H2 atmosphere at acidic conditions at a temperature between 180 and 250° C. and a pressure between 10 and 200 bar.

The invention relates to methods of hydrodeoxygenation of oxygenated compounds into compounds with unsaturated carbon-carbon bonds, comprising the steps of: a) providing a reaction mixture comprising, an oxygenated compound containing one or more of a hydroxyl, keto or aldehyde group, an ionic liquid, a homogeneous metal catalyst, and carbon monoxide or a carbon monoxide releasing compound, b) reacting said reaction mixture under a H2 atmosphere at acidic conditions at a temperature between 180 and 250° C. and a pressure between 10 and 200 bar.

The present disclosure provides methods to produce 5-(halomethyl)furfural, including 5-(chloromethyl)furfural, by acid-catalyzed conversion of C6 saccharides, including isomers thereof, polymers thereof, and certain derivatives thereof. The methods make use of acids with lower concentrations, and allows for conversion of sugars into 5-(halomethyl)furfural at higher temperatures and faster reaction or residence times.

Disclosed is chemical compounds C that are derivatives of norbixin and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal pigment epithelium and more particularly in the context of age-related macular degeneration (AMD) and Stargardt's disease.

Disclosed is chemical compounds C that are derivatives of norbixin and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal pigment epithelium and more particularly in the context of age-related macular degeneration (AMD) and Stargardt's disease.

Provided herein are lipidic furan, pyrrole, and thiophene compounds, compositions, and methods using such compounds and compositions for the treatment of atrophic vaginitis. Specifically, the invention includes administering an effective amount of a compound of Formula I, I′, or I″, or a pharmaceutically acceptable composition, salt, isotopic analog, prodrug, or combination thereof, to a subject suffering from atrophic vaginitis.